Advertisement
Advertisement
U.S. Markets open in 9 hrs 14 mins
Advertisement
Advertisement
Advertisement
Advertisement

Harvest One Cannabis Inc. (HRVOF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0497-0.0024 (-4.68%)
At close: 10:12AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0521
Open0.0516
BidN/A x N/A
AskN/A x N/A
Day's Range0.0497 - 0.0530
52 Week Range0.0410 - 0.4547
Volume112,500
Avg. Volume95,559
Market Cap12.555M
Beta (5Y Monthly)1.96
PE Ratio (TTM)N/A
EPS (TTM)-0.0870
Earnings DateNov 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Harvest One and its Brands LivRelief (TM) and Dream Water (TM) Report Continued Positive Results for Fiscal Q1 2022

    Ongoing strategic focus on transformation to a health and wellness CPG company that is uniquely positioned in the cannabis space providing well-respected brands and innovative products to the emerging marketplace Improved net revenue with 12% growth quarter-over-quarter despite on-going COVID travel restrictionsImproved gross profit margin, 33% in fiscal Q1 2022 vs. 29% in fiscal Q1 2021 Selling, general and administrative ("SG&A") expenses reduced by 37% quarter-over-quarter Improved adjusted e

  • ACCESSWIRE

    The Power Play by The Market Herald Releases New Interviews

    VANCOUVER, BC / ACCESSWIRE / November 10, 2021 / The Power Play by The Market Herald has announced the release of a new interview with TomaGold, Nextech AR, LUXXFOLIO, Harvest One, X-Terra, Alvopetro, and Vejii Holdings to discuss their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

  • Newsfile

    Harvest One and its Brands LivRelief (TM) and Dream Water (TM) Report Positive Q4 2021 and Year End Financial Results

    Strategic transformation to a uniquely positioned health and wellness company that provides top selling brands to the global marketplaceImproved net revenue by 2.2% growth year over year despite aggressive COVID travel restrictionsImproved gross profit, 24% in fiscal 2021 vs. 9% in fiscal 2020 Lowered selling, general and administrative ("SG&A") expenses by 28% year over year Improved adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA")(1) by 33% year over yearImpro

Advertisement
Advertisement